zepbound is tirzepatide or semaglutide vs GLP-1 vs Wegovy Zepbound: The newest obesity medication
Description
95% CI, 0.22 to 4.34
Systemic signs severe nausea, vomiting that prevents eating, or a resting heart rate above 100 bpm are listed in the Mounjaro FDA prescribing information
As a dual agonist, it activates two separate hormone receptors in your body: GLP-1 and GIP
Refrigerate between 2 and 8 degrees Celsius
Tirzepatide has shown reductions of up to 2.4% , making it slightly more effective for diabetes management
